YAP-TEAD-driven CPA4 promotes NF2-deficient meningioma growth
Kentaro Mineji, Katerina Petrosky, Ryosuke Otsuji, Yasuhide Makino, Yuji Kibe, Eita Uchida, Daichi Hagita, Neha Singaravelan, Yukitomo Ishi, Shigeru Yamaguchi, Long‐Sheng Chang, Samantha Gadd, Rintaro Hashizume
This study identifies CPA4 as a YAP-TEAD-driven effector in NF2-deficient meningioma, showing its role in tumor growth and sensitivity to TEAD inhibitors.
bioRxiv · Aug 7, 2026 · PreprintCancer Biology